2022
DOI: 10.1016/j.jcf.2021.09.013
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics of electrolyte imbalance and pseudo-bartter syndrome in hospitalized cystic fibrosis children and adolescents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…Serum hematological and biochemical evaluations were performed at the diagnosis of CF. Serum electrolyte levels were considered normal within the following ranges: 135–145 mEq/L for sodium, 3–4.5 mEq/L for potassium, and 95–110 mEq/L for chloride [ 13 ].…”
Section: Methodsmentioning
confidence: 99%
“…Serum hematological and biochemical evaluations were performed at the diagnosis of CF. Serum electrolyte levels were considered normal within the following ranges: 135–145 mEq/L for sodium, 3–4.5 mEq/L for potassium, and 95–110 mEq/L for chloride [ 13 ].…”
Section: Methodsmentioning
confidence: 99%
“…19 The SEM image shows that the PMN comprised aggregated particles with pores averaging 1.0 μm in diameter (Fig. 3 29 suggesting that the electrode can be applied to the measurement of intradermal Na + concentrations. The unique feature of the present sensor system is the simple single-needle configuration, which could allow lower invasive transdermal analysis than the conventional MN-based sensing with multiple needle electrodes.…”
Section: Figure 2amentioning
confidence: 99%
“…Work is needed to identify the most accurate in vitro and in vivo tests to predict CFTR function and clinical response to help guide individual personalized therapies. This may include a combination of organoid technology, sweat chloride concentration, nasal potential difference and intestinal current measurement [ 24 , 76 , [108] , [109] , [110] , [111] ]. It is anticipated that by investigating genetic and non-genetic modifiers, we may improve our understanding of phenotypical variation in response to CFTR therapy [ 112 , 113 ].…”
Section: Novel Therapiesmentioning
confidence: 99%